Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a dismal prognosis, especially when diagnosed at advanced stages. Surgical resection of the primary lesion, liver-directed therapies, and orthotropic liver transplantation are employed in localized disease depending upon the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tella, Sri Harsha, Mahipal, Amit, Kommalapati, Anuhya, Jin, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886547/
https://www.ncbi.nlm.nih.gov/pubmed/31819517
http://dx.doi.org/10.2147/OTT.S214870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886547/
https://www.ncbi.nlm.nih.gov/pubmed/31819517
http://dx.doi.org/10.2147/OTT.S214870

Ejemplares similares